Leadership
From scientific innovation to commercial success, we know what it takes.
With decades of experience advancing blood cancer therapies from discovery through global launch, Geron’s leadership team has built organizations, navigated complex regulatory pathways, and expanded access to medicines around the world. Together, they are guiding Geron as we build on our foundation to become a leading hematology company and pursue more meaningful moments for people living with blood cancer.
Executive Leadership Team
Joseph Eid, M.D.
Executive Vice President, Research and Development, Chief Medical Officer
Ahmed ElNawawi (“Nawawi”)
Executive Vice President, Chief Commercial Officer
Shannon T. Odam
Executive Vice President, Chief People Officer
Chinmaya Rath
Senior Vice President, Chief Business Officer
Bryan Ridgell
Senior Vice President, Portfolio and Project Management and Chief of Staff
Michelle Robertson
Executive Vice President, Chief Financial Officer and Treasurer
Dawn Schottlandt
Senior Vice President, Investor Relations and Corporate Affairs
Shanthakumar (Shantha) Tyavanagimatt, Ph.D.
Senior Vice President, Chief Technical Officer
Timothy Williams
Executive Vice President, Chief Legal Officer and Corporate Secretary
Board of Directors
Harout Semerjian
President and Chief Executive Officer, Board of Directors Member
Patricia S. Andrews
Board of Directors Member, Audit Committee
Dawn C. Bir
Board of Directors Member, Chair of the Nominating and Corporate Governance Committee (Chair), Corporate Committee
Constantine Chinoporos
Board of Directors Member
Susan M. Molineaux, Ph.D.
Board of Directors Member, Compensation Committee (Chair), Nominating and Corporate Governance Committee
Elizabeth G. O’Farrell
Chair of the Board, Audit Committee (Chair)
